236 related articles for article (PubMed ID: 32227274)
21. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.
Wu MY; Yao L; Wang Y; Zhu XY; Wang XF; Tang PJ; Chen C
Respir Res; 2020 Jul; 21(1):171. PubMed ID: 32631317
[TBL] [Abstract][Full Text] [Related]
22. A contemporary look at COVID-19 medications: available and potentially effective drugs.
Alshaeri HK; Natto ZS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9188-9195. PubMed ID: 32965013
[TBL] [Abstract][Full Text] [Related]
23. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
24. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.
Chen Q; Quan B; Li X; Gao G; Zheng W; Zhang J; Zhang Z; Liu C; Li L; Wang C; Zhang G; Li J; Dai Y; Yang J; Han W
J Med Virol; 2020 Jun; 92(6):683-687. PubMed ID: 32162699
[TBL] [Abstract][Full Text] [Related]
25. The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Vahedi E; Ghanei M; Ghazvini A; Azadi H; Izadi M; Panahi Y; Fathi S; Salesi M; Saadat SH; Ghazale AH; Rezapour M; Mozafari A; Zand N; Parsaei MR; Ranjkesh MH; Jafari R; Movaseghi F; Darabi E
Daru; 2020 Dec; 28(2):507-516. PubMed ID: 32562159
[TBL] [Abstract][Full Text] [Related]
26. A comparative study on the time to achieve negative nucleic acid testing and hospital stays between danoprevir and lopinavir/ritonavir in the treatment of patients with COVID-19.
Zhang Z; Wang S; Tu X; Peng X; Huang Y; Wang L; Ju W; Rao J; Li X; Zhu D; Sun H; Chen H
J Med Virol; 2020 Nov; 92(11):2631-2636. PubMed ID: 32501538
[TBL] [Abstract][Full Text] [Related]
27. Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only).
Panteghini M
Clin Chem Lab Med; 2020 Aug; 58(12):1979-1981. PubMed ID: 32829312
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery.
Pereda R; González D; Rivero HB; Rivero JC; Pérez A; Lopez LDR; Mezquia N; Venegas R; Betancourt JR; Domínguez RE; Nodarse H
J Interferon Cytokine Res; 2020 Dec; 40(12):578-588. PubMed ID: 33337933
[TBL] [Abstract][Full Text] [Related]
29. Abnormal myocardial enzymes in the prediction of mortality and hypertension in COVID-19 patients: a retrospective study.
Sha S; Liu M; Sun M; Xiao L; Chang Q; Chen Y; Huang J
Aging (Albany NY); 2022 Nov; 14(21):8585-8594. PubMed ID: 36326681
[TBL] [Abstract][Full Text] [Related]
30. CD8
Liu L; Chen Z; Du Y; Gao J; Li J; Deng T; Chen C; Wang L; Yang Y; Liu C
Sci Rep; 2021 Jan; 11(1):2169. PubMed ID: 33500507
[TBL] [Abstract][Full Text] [Related]
31. Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patients.
Ayten O; Saylan B
S Afr J Infect Dis; 2020; 35(1):233. PubMed ID: 34485485
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of biochemical characteristics of 183 COVID-19 patients: A retrospective study.
Mir SM; Tahamtan A; Nikoo HR; Arabi MS; Moradi AW; Ardakanian S; Tabarraei A
Gene Rep; 2022 Mar; 26():101448. PubMed ID: 34869941
[TBL] [Abstract][Full Text] [Related]
33. Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19.
Binois Y; Hachad H; Salem JE; Charpentier J; Lebrun-Vignes B; Pène F; Cariou A; Chiche JD; Mira JP; Nguyen LS
Kidney Int Rep; 2020 Oct; 5(10):1787-1790. PubMed ID: 32838087
[No Abstract] [Full Text] [Related]
34. Lopinavir-Ritonavir Associated Acute Kidney Injury Is Not Related to Crystalluria in Critically Ill COVID-19 Patients.
Arrestier R; Stehle T; Letavernier E; Mekontso-Dessap A
Kidney Int Rep; 2020 Nov; 5(11):2119. PubMed ID: 32869007
[No Abstract] [Full Text] [Related]
35. Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.
Spagnuolo V; Guffanti M; Galli L; Poli A; Querini PR; Ripa M; Clementi M; Scarpellini P; Lazzarin A; Tresoldi M; Dagna L; Zangrillo A; Ciceri F; Castagna A;
Sci Rep; 2021 May; 11(1):10699. PubMed ID: 34001918
[No Abstract] [Full Text] [Related]
36. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Hung IF; Lung KC; Tso EY; Liu R; Chung TW; Chu MY; Ng YY; Lo J; Chan J; Tam AR; Shum HP; Chan V; Wu AK; Sin KM; Leung WS; Law WL; Lung DC; Sin S; Yeung P; Yip CC; Zhang RR; Fung AY; Yan EY; Leung KH; Ip JD; Chu AW; Chan WM; Ng AC; Lee R; Fung K; Yeung A; Wu TC; Chan JW; Yan WW; Chan WM; Chan JF; Lie AK; Tsang OT; Cheng VC; Que TL; Lau CS; Chan KH; To KK; Yuen KY
Lancet; 2020 May; 395(10238):1695-1704. PubMed ID: 32401715
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
39. Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
Zhu Z; Lu Z; Xu T; Chen C; Yang G; Zha T; Lu J; Xue Y
J Infect; 2020 Jul; 81(1):e21-e23. PubMed ID: 32283143
[TBL] [Abstract][Full Text] [Related]
40. Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China.
Liu J; Liu Z; Jiang W; Wang J; Zhu M; Song J; Wang X; Su Y; Xiang G; Ye M; Li J; Zhang Y; Shen Q; Li Z; Yao D; Song Y; Yu K; Luo Z; Ye L
Clin Respir J; 2021 Mar; 15(3):293-309. PubMed ID: 33090710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
